Aster CMI Hospital Launches ARISE, Dedicated Robotic Spine Surgery Institute

IMT News Desk
IMT News Desk
· 3 min read
Aster CMI launches ARISE, a robotic spine surgery institute to deliver safer, precise, minimally invasive care and advance neurosurgical innovation.

Aster CMI Hospital has announced the launch of ARISE (Aster Robotic Institute for Spine Excellence), a dedicated centre focused on advancing robotic-assisted and minimally invasive spine surgery through clinical excellence, innovation, research, education and training. ARISE has been established to integrate advanced robotic technologies, precision-driven surgical techniques, multidisciplinary expertise and structured training under one platform, with the goal of improving outcomes for patients with complex spine disorders.

The institute aims to set new benchmarks in robotic spine surgery by combining state-of-the-art technology with evidence-based clinical care and a strong emphasis on education for the next generation of spine surgeons. By bringing together neurosurgeons, spine specialists, anaesthesiologists, rehabilitation experts and technology partners, ARISE is positioned to deliver comprehensive care for a wide spectrum of spinal conditions, from degenerative disorders to complex deformities and trauma.

“Robotic technology is reshaping the future of spine surgery by enabling greater precision, enhanced safety and improved patient outcomes,” said Dr Ravi Gopal Varma, Director – Aster Global Centre of Excellence in Neurosciences and Lead Consultant – Neurosurgery, Aster CMI Hospital, Karnataka. He noted that through ARISE, the team aims not only to deliver world-class robotic spine care but also to build a centre of innovation, research and education that contributes to the advancement of neurosciences globally.

Dr Akshay Hari, Consultant- Neurosurgery and Spine Surgery, Aster CMI Hospital, added that robotic-assisted spine surgery allows surgeons to plan procedures with exceptional accuracy and execute them with greater precision, supporting minimally invasive approaches. According to him, this translates into reduced blood loss, faster recovery, shorter hospital stays and better long-term outcomes for patients, and ARISE provides the ideal platform to further advance these technologies and make them more widely accessible.

Commenting on the launch, Dr Prashanth N, CEO- Aster Hospitals, Karnataka, said that Aster continuously invests in technologies and centres of excellence that redefine patient care, and the establishment of ARISE reflects the organisation’s long-term vision of making advanced robotic spine surgery accessible while strengthening Bengaluru’s position as a destination for world-class neurosciences care. He emphasised that the hospital remains committed to delivering innovative, patient-centric healthcare through a combination of clinical excellence and technology.

With the launch of ARISE, Aster CMI Hospital further consolidates its position as one of India’s leading centres for neurosciences by uniting highly experienced specialists, advanced robotic platforms, ongoing research and structured education programmes. The institute is expected to provide safer, smarter and more precise treatment for patients requiring complex spine procedures, while also nurturing future leaders in the field of robotic and minimally invasive spine surgery.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk